Role of Recipient-Derived Cells in Allograft Neointima Formation and Stent Response
Author Information
Author(s): Ma Xiaoli, Hibbert Benjamin, White Dawn, Seymour Richard, Whitman Stewart C., O'Brien Edward R.
Primary Institution: University of Ottawa Heart Institute
Hypothesis
What is the origin of neointimal cells in allografts with or without stents?
Conclusion
Host-derived blood-borne cells significantly contribute to neointima formation in allograft vasculopathy and the response to stent implantation.
Supporting Evidence
- 72.1% of neointimal cells in non-stented allografts were of recipient origin.
- 81.5% of neointimal cells in stented allografts were of recipient origin.
- Neointima area was 58% greater in stented vs. non-stented allograft segments.
Takeaway
This study shows that cells from the body help build up the inner layer of blood vessels after a stent is put in, which can cause problems after heart transplants.
Methodology
A rabbit model was used to study the contribution of recipient-derived cells to neointima formation after stent implantation, employing techniques like in situ hybridization and quantitative PCR.
Potential Biases
Potential bias in the interpretation of the role of host-derived cells due to the limitations of the experimental model.
Limitations
The study only assessed early engraftment of host-derived cells, and it is unclear if these cells survive and contribute to mature lesion formation.
Participant Demographics
New Zealand White rabbits, both male and female, were used in the study.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website